Monoclonal Antibodies for Lupus

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Current Drug Use Criteria New Drug Evaluation
anifrolumab-fnia SAPHNELO VIAL N PA Document  
belimumab BENLYSTA AUTO INJCT N PA Document May 24, 2018
belimumab BENLYSTA SYRINGE N PA Document May 24, 2018
belimumab BENLYSTA VIAL N PA Document May 24, 2018